245 related articles for article (PubMed ID: 27373856)
41. The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
Soraoka H; Oniki K; Matsuda K; Ono T; Taharazako K; Uchiyashiki Y; Kamihashi R; Kita A; Takashima A; Nakagawa K; Yasui-Furukori N; Kadowaki D; Miyata K; Saruwatari J
Biol Pharm Bull; 2016; 39(9):1468-74. PubMed ID: 27582327
[TBL] [Abstract][Full Text] [Related]
42. Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes.
Kawakami Z; Ikarashi Y; Kase Y
Eur J Pharmacol; 2010 Jan; 626(2-3):154-8. PubMed ID: 19818347
[TBL] [Abstract][Full Text] [Related]
43. Anti-allergic mechanisms of Japanese herbal medicine, yokukansan on mast cells.
Yamamura K; Kato S; Kato TA; Mizoguchi Y; Monji A; Kanba S; Furue M; Takeuchi S
J Dermatol; 2014 Sep; 41(9):808-14. PubMed ID: 25156212
[TBL] [Abstract][Full Text] [Related]
44. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
[TBL] [Abstract][Full Text] [Related]
45. The role of the seven crude drug components in the sleep-promoting effect of Yokukansan.
Ogawa Y; Fujii Y; Sugiyama R; Konishi T
J Ethnopharmacol; 2016 Jan; 177():19-27. PubMed ID: 26611914
[TBL] [Abstract][Full Text] [Related]
46. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
[TBL] [Abstract][Full Text] [Related]
47. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
[TBL] [Abstract][Full Text] [Related]
48. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
49. Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.
Tabuchi M; Mizuno K; Mizoguchi K; Hattori T; Kase Y
Front Pharmacol; 2017; 8():235. PubMed ID: 28491038
[TBL] [Abstract][Full Text] [Related]
50. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
Shoji H; Mizoguchi K
J Ethnopharmacol; 2013 Aug; 149(1):93-102. PubMed ID: 23770052
[TBL] [Abstract][Full Text] [Related]
51. Potential Application of Yokukansan as a Remedy for Parkinson's Disease.
Jang JH; Jung K; Kim JS; Jung I; Yoo H; Moon C
Evid Based Complement Alternat Med; 2018; 2018():1875928. PubMed ID: 30671124
[TBL] [Abstract][Full Text] [Related]
52. Properties, Pharmacology, and Pharmacokinetics of Active Indole and Oxindole Alkaloids in
Kushida H; Matsumoto T; Ikarashi Y
Front Pharmacol; 2021; 12():688670. PubMed ID: 34335255
[No Abstract] [Full Text] [Related]
53. Potential usefulness of the kampo medicine yokukansan, containing uncaria hook, for paediatric emotional and behavioural disorders: a case series.
Tanaka Y; Sakiyama T
Evid Based Complement Alternat Med; 2013; 2013():502726. PubMed ID: 24204394
[TBL] [Abstract][Full Text] [Related]
54. Impact of Gut Microbiota on the Pharmacokinetics of Glycyrrhizic Acid in Yokukansan, a Kampo Medicine.
Ishida T; Jobu K; Kawada K; Morisawa S; Kawazoe T; Shiraishi H; Fujita H; Nishimura S; Kanno H; Nishiyama M; Ogawa K; Morita Y; Hanazaki K; Miyamura M
Biol Pharm Bull; 2022; 45(1):104-113. PubMed ID: 34980772
[TBL] [Abstract][Full Text] [Related]
55. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
Kung FC; Ishii R; Liu HC; Takeda M
Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
[TBL] [Abstract][Full Text] [Related]
56. Effect of Yokukansan and Yokukansankachimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social Isolation-Reared Mice.
Iba H; Watanabe T; Matsuzawa K; Saimiya M; Tanaka M; Nagao M; Moriyama H; Kubota K; Katsurabayashi S; Iwasaki K
Biol Pharm Bull; 2019; 42(12):2009-2015. PubMed ID: 31787717
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the Effects of Yokukansan and Yokukansankachimpihange on Glutamate Uptake by Cultured Astrocytes and Glutamate-Induced Excitotoxicity in Cultured PC12 Cells.
Kawakami Z; Omiya Y; Mizoguchi K
Evid Based Complement Alternat Med; 2019; 2019():9139536. PubMed ID: 31263507
[TBL] [Abstract][Full Text] [Related]
58. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice.
Fujiwara H; Takayama S; Iwasaki K; Tabuchi M; Yamaguchi T; Sekiguchi K; Ikarashi Y; Kudo Y; Kase Y; Arai H; Yaegashi N
Neuroscience; 2011 Apr; 180():305-13. PubMed ID: 21303686
[TBL] [Abstract][Full Text] [Related]
59. Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat.
Furuya M; Miyaoka T; Tsumori T; Liaury K; Hashioka S; Wake R; Tsuchie K; Fukushima M; Ezoe S; Horiguchi J
J Neuroinflammation; 2013 Dec; 10():145. PubMed ID: 24305622
[TBL] [Abstract][Full Text] [Related]
60. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.
Murakami Y; Zhao Q; Harada K; Tohda M; Watanabe H; Matsumoto K
Pharmacol Biochem Behav; 2005 Jul; 81(3):616-25. PubMed ID: 15936808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
